Chorioamnionitis and Culture-Confirmed, Early-Onset Neonatal Infections
- PMID: 26719293
- PMCID: PMC4702021
- DOI: 10.1542/peds.2015-2323
Chorioamnionitis and Culture-Confirmed, Early-Onset Neonatal Infections
Abstract
Background: Current guidelines for prevention of neonatal group B streptococcal disease recommend diagnostic evaluations and empirical antibiotic therapy for well-appearing, chorioamnionitis-exposed newborns. Some clinicians question these recommendations, citing the decline in early-onset group B streptococcal disease rates since widespread intrapartum antibiotic prophylaxis implementation and potential antibiotic risks. We aimed to determine whether chorioamnionitis-exposed newborns with culture-confirmed, early-onset infections can be asymptomatic at birth.
Methods: Multicenter, prospective surveillance for early-onset neonatal infections was conducted during 2006-2009. Early-onset infection was defined as isolation of a pathogen from blood or cerebrospinal fluid collected ≤ 72 hours after birth. Maternal chorioamnionitis was defined by clinical diagnosis in the medical record or by histologic diagnosis by placental pathology. Hospital records of newborns with early-onset infections born to mothers with chorioamnionitis were reviewed retrospectively to determine symptom onset.
Results: Early-onset infections were diagnosed in 389 of 396,586 live births, including 232 (60%) chorioamnionitis-exposed newborns. Records for 229 were reviewed; 29 (13%) had no documented symptoms within 6 hours of birth, including 21 (9%) who remained asymptomatic at 72 hours. Intrapartum antibiotic prophylaxis exposure did not differ significantly between asymptomatic and symptomatic infants (76% vs 69%; P = .52). Assuming complete guideline implementation, we estimated that 60 to 1400 newborns would receive diagnostic evaluations and antibiotics for each infected asymptomatic newborn, depending on chorioamnionitis prevalence.
Conclusions: Some infants born to mothers with chorioamnionitis may have no signs of sepsis at birth despite having culture-confirmed infections. Implementation of current clinical guidelines may result in early diagnosis, but large numbers of uninfected asymptomatic infants would be treated.
Copyright © 2016 by the American Academy of Pediatrics.
Conflict of interest statement
Figures


Similar articles
-
Incidence of fever in labor and risk of neonatal sepsis.Am J Obstet Gynecol. 2017 Jun;216(6):596.e1-596.e5. doi: 10.1016/j.ajog.2017.02.022. Epub 2017 Feb 16. Am J Obstet Gynecol. 2017. PMID: 28216060
-
The prevention of early-onset neonatal group B streptococcal disease.J Obstet Gynaecol Can. 2013 Oct;35(10):939-948. doi: 10.1016/S1701-2163(15)30818-5. J Obstet Gynaecol Can. 2013. PMID: 24165063 Review.
-
Clinical and Microbiologic Characteristics of Early-onset Sepsis Among Very Low Birth Weight Infants: Opportunities for Antibiotic Stewardship.Pediatr Infect Dis J. 2017 May;36(5):477-481. doi: 10.1097/INF.0000000000001473. Pediatr Infect Dis J. 2017. PMID: 28403049 Free PMC article.
-
Clinical Monitoring of Well-Appearing Infants Born to Mothers With Chorioamnionitis.Pediatrics. 2018 Apr;141(4):e20172056. doi: 10.1542/peds.2017-2056. Pediatrics. 2018. PMID: 29599112
-
Preventing neonatal group B streptococcal infection. Intrapartum antibiotic prophylaxis in some high-risk situations.Prescrire Int. 2011 Mar;20(114):72-7. Prescrire Int. 2011. PMID: 21648230 Review.
Cited by
-
Chorioamnionitis and subsequent bronchopulmonary dysplasia in very-low-birth weight infants: a 25-year cohort.J Perinatol. 2016 Dec;36(12):1045-1048. doi: 10.1038/jp.2016.138. Epub 2016 Sep 1. J Perinatol. 2016. PMID: 27583395
-
Quality and Clinical Outcomes Associated with a Gentamicin Use System Change for Managing Chorioamnionitis.J Med Syst. 2017 Nov 9;41(12):202. doi: 10.1007/s10916-017-0856-7. J Med Syst. 2017. PMID: 29124501
-
Neonate Bloodstream Infections in Organization for Economic Cooperation and Development Countries: An Update on Epidemiology and Prevention.J Clin Med. 2019 Oct 21;8(10):1750. doi: 10.3390/jcm8101750. J Clin Med. 2019. PMID: 31640253 Free PMC article. Review.
-
Neuroprotection from acute brain injury in preterm infants.Paediatr Child Health. 2019 Jul;24(4):276-290. doi: 10.1093/pch/pxz056. Epub 2019 Jun 21. Paediatr Child Health. 2019. PMID: 31239818 Free PMC article. Review.
-
Early-Onset Neonatal Sepsis 2015 to 2017, the Rise of Escherichia coli, and the Need for Novel Prevention Strategies.JAMA Pediatr. 2020 Jul 1;174(7):e200593. doi: 10.1001/jamapediatrics.2020.0593. Epub 2020 Jul 6. JAMA Pediatr. 2020. PMID: 32364598 Free PMC article.
References
-
- Schuchat A, Deaver-Robinson K, Plikaytis BD, Zangwill KM, Mohle-Boetani J, Wenger JD; Active Surveillance Study Group . Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J. 1994;13(7):623–629 - PubMed
-
- Schuchat A. Neonatal group B streptococcal disease—screening and prevention. N Engl J Med. 2000;343(3):209–210 - PubMed
-
- Verani JR, McGee L, Schrag SJ Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1–36 - PubMed
Publication types
MeSH terms
Grants and funding
- U10 HD027856/HD/NICHD NIH HHS/United States
- U10 HD021373/HD/NICHD NIH HHS/United States
- U10 HD021385/HD/NICHD NIH HHS/United States
- UG1 HD087226/HD/NICHD NIH HHS/United States
- U10 HD053124/HD/NICHD NIH HHS/United States
- U10 HD053119/HD/NICHD NIH HHS/United States
- U10 HD021364/HD/NICHD NIH HHS/United States
- U10 HD027880/HD/NICHD NIH HHS/United States
- UG1 HD027853/HD/NICHD NIH HHS/United States
- U10 HD053109/HD/NICHD NIH HHS/United States
- UG1 HD087229/HD/NICHD NIH HHS/United States
- UG1 HD040689/HD/NICHD NIH HHS/United States
- M01 RR008084/RR/NCRR NIH HHS/United States
- UG1 HD053089/HD/NICHD NIH HHS/United States
- U10 HD040689/HD/NICHD NIH HHS/United States
- U10 HD040492/HD/NICHD NIH HHS/United States
- U10 HD027853/HD/NICHD NIH HHS/United States
- U10 HD027904/HD/NICHD NIH HHS/United States
- UG1 HD027856/HD/NICHD NIH HHS/United States
- UG1 HD034216/HD/NICHD NIH HHS/United States
- U10 HD027871/HD/NICHD NIH HHS/United States
- UG1 HD027904/HD/NICHD NIH HHS/United States
- U10 HD027851/HD/NICHD NIH HHS/United States
- UG1 HD040492/HD/NICHD NIH HHS/United States
- UG1 HD021364/HD/NICHD NIH HHS/United States
- UG1 HD027880/HD/NICHD NIH HHS/United States
- UL1 TR001117/TR/NCATS NIH HHS/United States
- UG1 HD027851/HD/NICHD NIH HHS/United States
- UL1 RR025008/RR/NCRR NIH HHS/United States
- U10 HD034216/HD/NICHD NIH HHS/United States
- U10 HD036790/HD/NICHD NIH HHS/United States
- UG1 HD068278/HD/NICHD NIH HHS/United States
- U10 HD053089/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases